MiMedx Group's 8.9% pullback not enough to deter long-term shareholders, up 70% over 3 years.

MiMedx Group's share price has dropped 21% in the last month, but is still up 70% over the past three years. Despite a recent 8.9% pullback, the company's fundamentals have improved, moving from a loss to profitability. Insiders have been buying shares, and the company's EPS has tracked positively over time. However, future earnings will be crucial to determining if current shareholders will make a profit.